Menu

CME Corner

Active Programs

Treatment Patterns in Family Medicine: The Role of the Primary Care Clinician in Patient-Centered Management of IBD/Module 3: Improving Adherence, Monitoring, and Communication

Inflammatory bowel disease is commonly associated with a wide range of extraintestinal manifestations that may appear in a variety of locations throughout the body. This activity, the third in a 3-part series, will review these manifestations and the primary care clinician’s role in identifying/investigating them. It will also examine patient non-adherence to medication and offer suggestions for f ...

  • i-Newsletter i-Newsletter
  • AAFP
  • AANP
  • AAPA

Treatment Patterns in Family Medicine: The Role of the Primary Care Clinician in Patient-Centered Management of IBD/Module 2: Escalating Therapy, Addressing Treatment Risks, and Co-Managing With Specialists

Patients with inflammatory bowel disease (IBD) who present with moderate to severe disease, or who relapse after treatment for mild disease will often require treatment with additional forms of therapy. Primary care clinicians are on the front line for monitoring their patients for treatment response and adverse events. This activity, the second in a 3-part series, addresses escalation of therapy ...

  • i-Newsletter i-Newsletter
  • AAFP
  • AANP
  • AAPA

Treatment Patterns in Family Medicine: The Role of the Primary Care Clinician in Patient-Centered Management of IBD/Module 1: Diagnosis and Initial Treatment Options

Inflammatory bowel disease (IBD) can be challenging to diagnose because of its heterogeneous and somewhat ambiguous clinical presentation. Despite the challenges, primary care clinicians are on the front line for assessment and initial diagnosis of these patients. Once diagnosed, even if placed under the care of a gastroenterologist, these patients will require life-long care. This activity, the f ...

  • i-Newsletter i-Newsletter
  • AAFP
  • AANP
  • AAPA

IBD Diagnosis and Management: Untangling the Complexities

Inflammatory bowel disease (IBD), which comprises ulcerative colitis (UC) and Crohn’s disease (CD), is a complex condition that can be difficult to identify and treat. Carefully tailoring and monitoring care is essential because therapeutic goals and strategies differ by disease severity. New data available to clinicians are revising the management paradigm for IBD as well as the definition of dee ...

  • Mobile + Online on QuantiaMD
  • ACCME

Expired Programs

Achieving Optimal Outcomes in Patients With Inflammatory Bowel Disease

NOTE: This activity was presented as a live visiting faculty grand rounds series beginning on September 22, 2015. Participants who received credit for attending any of the live presentations are not eligible to receive credit for this online release. IBD is a chronic progressive inflammatory disorder of the GI tract, which includes Crohn’s disease (CD) and ulcerative colitis (UC). CD and UC ar ...

  • Online Presentation Online Presentation
  • ACCME

Current Guidelines and Future Directions in Colorectal Cancer Treatment

NOTE: This activity was presented as a live visiting faculty grand rounds series beginning on April 16, 2015. Participants who received credit for attending any of the live presentations are not eligible to receive credit for this online release. Colorectal cancer (CRC) is the second leading cause of cancer death in America, causing roughly 50,000 US deaths annually. Although mortality from co ...

  • Online Presentation Online Presentation
  • ACCME

Opioid-Induced Constipation: Improving Outcomes With Individualized, Evidence-Based Treatment

This activity will review the safety and efficacy of available therapies to prevent and treat opioid-induced constipation. It will also examine strategies for optimizing treatment selection and adjusting therapy when necessary to help patients achieve their treatment goals and improve their overall quality of life. ...

  • Reach MD / podcast
  • ACCME
Main Menu
EDITOR'S PICKS